latest
The roadmap is based on comprehensive data showing where AI technologies are likely to be used in the NHS
"It is important we achieve transformation through emerging technology, helping scalability to improve patient care throughout the country, and can understand impact on the system, pathways, and users." Dr Hatim Abdulhussein, clinical lead for the digital, artificial intelligence and robotics technologies in education (DART-Ed) programme , HEE
Health Education England has published a roadmap into how artificial intelligence (AI) will be used in the NHS.
The roadmap sets out the current landscape of AI technologies that could be used in the NHS, including the clinical areas that could benefit and the workforce members most likely to be impacted. The roadmap’s authors also created an interactive dashboard to display the findings clearly in graphical form.
The roadmap was developed in cooperation with Unity Insights, with support from NICE, NHS AI Lab and the NHS Accelerated Access Collaborative (AAC). The aim is to provide insights for NHS leaders into AI policy, education, regulation, innovation, digital transformation and workforce strategy. Part of the project involved creating a database of 240 AI technologies that could be used in the NHS.
Among the report’s findings are:
Dr Hatim Abdulhussein, clinical lead for the digital, artificial intelligence and robotics technologies in education (DART-Ed) programme at Health Education England, described the roadmap as an “invaluable asset in helping to understand the AI and data driven landscape in healthcare, and the implications this will have.” He added: “It is important we achieve transformation through emerging technology, helping scalability to improve patient care throughout the country, and can understand impact on the system, pathways, and users. We need to ensure the workforce is ready to support this aim and the insights from this roadmap will focus our efforts on education and training to achieve this.”
The authors of the roadmap note certain limitations to the exercise. The data collection, for example, “relied on publicly available data and did not seek to validate the claims and evidence publicised by the companies; therefore some benefits may be overstated, especially for technologies at an early stage of development.” They note that keeping the roadmap up to date is “critical to keeping the dashboard relevant and insightful.”